Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 436 of 5804
-
New combo therapy aims to tackle melanoma that resists treatment
Disease control Recruiting nowThere is a lack of strategies for patients who progress after responding to PD-1/l-1 in melanoma. High expression of Nectin4 in skin and melanomas may serve as a new target in advanced melanomas. The combination of enfortumab/vedotin (EV) and pembrolizumab has shown synergistic e…
Phase: PHASE2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control
Last updated Jun 26, 2026 17:53 UTC
-
New device aims to seal brain aneurysms without surgery
Disease control Recruiting nowThe goal of this clinical trial is to collect additional data to demonstrate if the Contour Neurovascular System (CNS) is a safe and effective treatment of wide-necked, saccular, intracranial aneurysms. Participants will: Undergo treatment with the Contour Neurovascular System …
Phase: NA • Sponsor: Cerus Endovascular, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Supercharged immune cells take on hard-to-treat cancers
Disease control Recruiting nowThe body has different ways of fighting infection and disease. No single way seems perfect for fighting cancers. This research study combines two different ways of fighting cancer: antibodies and T cells. Antibodies are types of proteins that protect the body from infectious dis…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill targets Hard-to-Treat cancers with specific gene mutation
Disease control Recruiting nowPhase 1/2, open-label study of ETX-636 in participants with advanced solid tumors
Phase: PHASE1, PHASE2 • Sponsor: Ensem Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a cell infusion free organ transplant patients from lifelong drugs?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and feasibility of inducing hematopoietic mixed chimerism to promote immune tolerance and potentially reduce the need for lifelong immunosuppression in pediatric and adult patients undergoing solid organ transplantation (S…
Phase: PHASE1 • Sponsor: Francisco Hernández Oliveros • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Shorter TB prevention regimens put to the test in major trial
Prevention Recruiting nowOur study rationale is based on: 1. Tuberculosis Preventive Treatment (TPT) is given to healthy people and needs to be safe; 2. Tuberculosis Preventive Treatment (TPT) with shorter regimens are superior with respect to acceptance, completion, and costs; 3. 4 months of Rifampin 1…
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Triple therapy aims to shrink liver tumors before surgery
Disease control Recruiting nowThe goal of this clinical trial is to learn if the neoadjuvant therapy of iIparomlimab and Tuvonralimab plus lenvatinib works to treat hepatocellular carcinoma(HCC) patients with high risk of recurrence. It will also learn about the safety of the combination of iIparomlimab and T…
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a tiny dose of radiation beat lymphoma with fewer side effects?
Disease control Recruiting nowThe researchers are doing this study to find out whether a very low dose of radiation therapy (VLDRT) is an effective treatment for people with follicular lymphoma (FL) or marginal zone lymphoma (MZL) and works as well as the standard dose of radiation therapy. The researchers wi…
Phase: PHASE3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New pill aims to cut dangerous lung Flare-Ups in bronchiectasis
Disease control Recruiting nowThis study is open to adults and adolescents aged 12 to under 18 with bronchiectasis. People can participate in this study if they produce sputum and have had flare-ups (also called exacerbations). The purpose of this study is to find out whether a medicine called BI 1291583 hel…
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Hope for kids with Friedreich's ataxia: drug already approved for teens now tested in younger children
Disease control Recruiting nowIn this study, researchers will learn more about omaveloxolone, also known as BIIB141 or SKYCLARYS®. Omaveloxolone is already approved for people with Friedreich's Ataxia (FA) who are 16 years of age or older. However, it is not yet available for younger teens and children. The m…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could stem cells save kidneys in diabetes?
Disease control Recruiting nowThis trial is to evaluate the efficacy and safety of umbilical cord-derived mesenchymal stromal cells (Amimestrocel ) in study subjects with progressive diabetic kidney disease (DKD), to investigate whether Amimestrocel can improve renal function or proteinuria of DKD patients.
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New 'Double Punch' CAR T-Cell therapy takes on tough blood cancers
Disease control Recruiting nowThis is a Phase I, prospective, dose-finding study to evaluate the safety, persistence, and clinical activity of GF-CART01 in subjects aged 18-70 with relapsed or refractory (R/R) B-cell hematological malignancies and failure of two-line or more standard chemotherapies or auto-he…
Phase: PHASE1 • Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Sweat away brain fog: exercise may slow Parkinson's cognitive decline
Disease control Recruiting nowCognitive impairment is an acknowledged feature of Parkinson's disease (PD) and often coexists with the classic motor symptoms since their onset. Cognitive symptoms of PD can be differentiated from other neurodegenerative diseases by the affected domains: typically, the executive…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hope for toddlers with sickle cell: drug may stop painful attacks
Prevention Recruiting nowThis post-authorisation safety and efficacy study (PRECISE PASS) evaluates the use of Xromi® (hydroxycarbamide 100 mg/mL oral solution) in children aged 9 months to under 2 years with sickle cell disease (SCD). The objective is to assess the safety profile and clinical effective…
Sponsor: Nova Laboratories Limited • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC
-
New hope for rare vasculitis: Three-Drug trial targets Non-Responders
Disease control Recruiting nowThe purpose of this study is to identify the most promising therapeutic strategy for patients with granulomatosis with polyangiitis and inadequate response to standard of care therapy. It will evaluate the efficacy to induce remission of three different salvage strategies includi…
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Nerve block injection may tame deadly heart storms
Disease control Recruiting nowThere is no randomized clinical study in the literature that evaluated the efficacy and safety of the stellate ganglion infiltration procedure in patients with electrical storm. So far, case reports and retrospective studies suggest that such a strategy should be considered in ca…
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New study aims to stop Post-Surgery confusion with sleep and brain training
Prevention Recruiting nowSleep disturbances, cognitive reserve, and continuing pain and inflammation are other risk factors contributing to delirium (confusion and agitation) and neurocognitive decline (in the long term) following heart surgery. Investigators aim to test a bundle of sleep optimization, c…
Phase: PHASE3 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Activism as medicine: new study tests if fighting racism can shield youth from depression
Prevention Recruiting nowOver 15 million people participated in racial justice protests nationwide during 2020-2021 spotlighting activism as a collective tool against structural racism and discrimination (SRD). SRD manifests as policies and practices (e.g., redlining, voter suppression, mass incarceratio…
Phase: NA • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Balloon treatment could stop hidden heart plaques from causing attacks
Disease control OngoingThe PASSIVATE-CAP study is an investigator-initiated, prospective, randomized, multicenter, open-label superiority trial focusing on acute coronary syndrome (ACS) patients with nonflow-limiting vulnerable plaques in nonculprit vessels. In this study, eligible patients were random…
Phase: NA • Sponsor: Yong He • Aim: Disease control
Last updated Jun 26, 2026 15:09 UTC
-
New antibody cocktail aims to stop rabies after multiple dog bites
Prevention OngoingThe objective of this real-world, prospective observational study is to evaluate the clinical effectiveness of zamerovimab and mazorelvimab injection (a human rabies monoclonal antibody cocktail) administered in combination with a standard rabies vaccine for post-exposure prophyl…
Sponsor: Synermore Biologics (Suzhou) Co., Ltd. • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC